NCT00001311View on ClinicalTrials.gov

Modified Intraocular Lens to Reduce Eye Inflammation After Cataract Surgery in Uveitis Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

April 30, 1992

Study Completion Date

February 28, 2001

Conditions
Cataracts
Interventions
DEVICE

heparin-surface modified intraocular lens

Trial Locations (1)

20892

National Eye Institute (NEI), Bethesda

All Listed Sponsors
lead

National Eye Institute (NEI)

NIH

NCT00001311 - Modified Intraocular Lens to Reduce Eye Inflammation After Cataract Surgery in Uveitis Patients | Biotech Hunter | Biotech Hunter